Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race
This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) shares fell about 4% on Friday after data indicated…
CMS cancels Medicare pilot offering GLP-1s to seniors at discount
WASHINGTON — The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through…
Lilly’s Foundayo hits 1,390 prescriptions in debut week
April 17 (Reuters) – Eli Lilly’s newly launched obesity pill was prescribed 1,390 times in the U.S. as…
Race for AI-developed drugs heats up: Wegovy-maker Novo Nordisk ties up with OpenAI after rival Eli Lilly seals deal
Danish drugmaker Novo Nordisk on Tuesday announced that it is collaborating with ChatGPT’s parent company, OpenAI, to bring…
Americans want weight-loss pills for cost and convenience
By Leah Douglas WASHINGTON, April 6 (Reuters) – Americans starting weight-loss medicines for the first time want lower…
Weight-Loss Injections Become Part of Pre-Wedding Preparation
HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest…
Generic versions of weight-loss drugs should arrive on Canadian pharmacy shelves this summer
With the expiration of the Canadian patents for weight-loss drugs Ozempic and Wegovy in January, experts are looking…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
Coming Soon: ‘Wegovy HD’
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
Ozempic Manufacturer Warned by FDA for Failing to Report Potential Side Effects
Packaging for the Ozempic injectable penCredit: Mario Tama/Getty NEED TO KNOW The FDA sent a “warning letter” to…
The Best Healthcare Stocks to Buy With $50 Right Now
It’s not hard to find healthcare stocks, including small-cap biotech companies, trading below $50 per share. However, many…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…